Intravitreous dexamethasone effects on different patterns of diabetic macular edema

Arch Ophthalmol. 2010 May;128(5):642-3. doi: 10.1001/archophthalmol.2010.44. Epub 2010 Mar 8.

Authors

Baruch D Kuppermann, Connie Chou, David V Weinberg, Scott M Whitcup, Julia A Haller, Mark S Blumenkranz; Dexamethasone DDS Phase II Study Group

Collaborators

Dexamethasone DDS Phase II Study Group:
Carl Awh, Brian Berger, Paul Bernstein, Mark S Blumenkranz, Herbert Cantrill, Thomas Chang, Stanley Chang, Connie Chou, Robert Diaz-Rohena, Bernard Doft, Pravin Dugel, Kurt Gitter, Bert Glaser, Stuart Green, Julia A Haller, Dennis Han, Bradley Jost, Baruch D Kuppermann, Hilel Lewis, Helen Li, Peter Liggett, Travis Meredith, George Novalis, Steven Sanislo, Steven Schwartz, Lawrence Singerman, Alan Wagner, George A Williams, David Wilson, Keye Wong, Lucy Young

PMID: 20212194
DOI: 10.1001/archophthalmol.2010.44

No abstract available

Publication types

Clinical Trial, Phase II
Letter
Randomized Controlled Trial

MeSH terms

Adult
Dexamethasone / administration & dosage*
Diabetic Retinopathy / classification
Diabetic Retinopathy / drug therapy*
Glucocorticoids / administration & dosage*
Humans
Injections
Macular Edema / classification
Macular Edema / drug therapy*
Retina / drug effects
Retina / pathology
Visual Acuity / physiology
Vitreous Body

Substances

Glucocorticoids
Dexamethasone

Associated data

ClinicalTrials.gov/NCT00035906